These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 208191)

  • 1. Effect of unsaturated fatty acids on separated form of human platelet cyclic nucleotide phosphodiesterase.
    Hirose S; Asano T; Hidaka H
    Thromb Res; 1978 Apr; 12(4):701-6. PubMed ID: 208191
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of SK&F 94120, an inhibitor of cyclic nucleotide phosphodiesterase type III, on human platelets.
    Simpson AW; Reeves ML; Rink TJ
    Biochem Pharmacol; 1988 Jun; 37(12):2315-20. PubMed ID: 2455518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of calmodulin-activated cyclic nucleotide phosphodiesterase by Triton X-100.
    Sharma RK; Wang JH
    Biochem Biophys Res Commun; 1981 May; 100(2):710-5. PubMed ID: 6268071
    [No Abstract]   [Full Text] [Related]  

  • 4. Actions of papaverine on intestinal smooth muscle and its inhibition of cyclic AMP and cyclic GMP phosphodiesterases.
    Miyamoto M; Takayanagi I; Ohkubo H; Takagi K
    Jpn J Pharmacol; 1976 Feb; (1):114-7. PubMed ID: 177797
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclic nucleotide phosphodiesterase inhibitors prevent aggregation of human platelets by raising cyclic AMP and reducing cytoplasmic free calcium mobilization.
    Lanza F; Beretz A; Stierlé A; Corre G; Cazenave JP
    Thromb Res; 1987 Mar; 45(5):477-84. PubMed ID: 3035738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous inhibition of guinea pig brain 2',3'-cyclic nucleotide 3'-phosphohydrolase and myelin protein synthesis by 2'-adenosine monophosphate.
    Starich GH; Dreiling CE
    Life Sci; 1980 Aug; 27(7):567-72. PubMed ID: 6252405
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological manipulation of tissue cyclic AMP by inhibitors. Effects of phosphodiesterase inhibitors on the functions of platelets and vascular endothelial cells.
    Tani T; Sakurai K; Kimura Y; Ishikawa T; Hidaka H
    Adv Second Messenger Phosphoprotein Res; 1992; 25():215-27. PubMed ID: 1372812
    [No Abstract]   [Full Text] [Related]  

  • 8. Isozyme-selective cyclic nucleotide phosphodiesterase inhibitors: biochemistry, pharmacology and therapeutic potential in asthma.
    Raeburn D; Souness JE; Tomkinson A; Karlsson JA
    Prog Drug Res; 1993; 40():9-32. PubMed ID: 8395068
    [No Abstract]   [Full Text] [Related]  

  • 9. Ascorbic acid inhibition of cyclic nucleotide phosphodiesterase acitivity.
    Malamud D; Kroll Y
    Proc Soc Exp Biol Med; 1980 Sep; 164(4):534-6. PubMed ID: 6251481
    [No Abstract]   [Full Text] [Related]  

  • 10. [Outer retinal rod segment cyclic nucleotide phosphodiesterase; protein inhibitor separation, bimodal effect of GTP].
    Dumler IL; Furaev VV; Etingof RN
    Dokl Akad Nauk SSSR; 1980; 253(6):1504-8. PubMed ID: 6253254
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of 2',3'-cyclic nucleotide 3'-phosphodiesterase activity from bovine, human and guinea pig brain.
    Sprinkle TJ; Knerr JR
    Brain Res; 1981 Jun; 214(2):455-9. PubMed ID: 6263423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of cyclic nucleotide phosphodiesterases as therapeutic agents.
    Murray KJ; England PJ
    Biochem Soc Trans; 1992 May; 20(2):460-4. PubMed ID: 1327922
    [No Abstract]   [Full Text] [Related]  

  • 13. Alkylxanthines as adenosine receptor antagonists and membrane phosphodiesterase inhibitors in central nervous tissue: evaluation of structure-activity relationships.
    Wu PH; Phillis JW; Nye MJ
    Life Sci; 1982 Dec; 31(25):2857-67. PubMed ID: 6298531
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of neoplastic cell growth by quiescent cells is mediated by serum concentration and cAMP phosphodiesterase inhibitors.
    Bertram JS; Bertram BB; Janik P
    J Cell Biochem; 1982; 18(4):515-38. PubMed ID: 6282911
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospects for selective cyclic nucleotide phosphodiesterase inhibitors in the treatment of bronchial asthma.
    Giembycz MA; Dent G
    Clin Exp Allergy; 1992 Mar; 22(3):337-44. PubMed ID: 1316796
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in the proteins of the outer segments of retinal rods in rats with tapeto-retinal dystrophies].
    Etingof RN; Ostapenko IA
    Vestn Akad Med Nauk SSSR; 1978; (10):3-8. PubMed ID: 212898
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of the functional role of cGMP-dependent protein kinase in intact human platelets using a specific activator 8-para-chlorophenylthio-cGMP.
    Butt E; Nolte C; Schulz S; Beltman J; Beavo JA; Jastorff B; Walter U
    Biochem Pharmacol; 1992 Jun; 43(12):2591-600. PubMed ID: 1321624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes.
    Nicholson CD; Challiss RA; Shahid M
    Trends Pharmacol Sci; 1991 Jan; 12(1):19-27. PubMed ID: 1848733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of cyclic nucleotide phosphodiesterase from the rod outer segments of the frog retina by 3-hydroxypyridine].
    Polianskiĭ NB; Smirnov LD; Shvedova AA; Kagan VE
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1984; (1):27-31. PubMed ID: 6199045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors.
    Beavo JA; Reifsnyder DH
    Trends Pharmacol Sci; 1990 Apr; 11(4):150-5. PubMed ID: 2159198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.